Lidocaine Jelly and Gels Market Trends, Industry & Size 2030
Global Lidocaine Jelly and Gels Market
Segments - by Product Types (Rx, and OTC), Applications (Interstitial Cystitis or Bladder Pain Syndrome, Pain Relief in Urethritis, Arthritis, Skin Discomfort, and Others), Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and E-Commerce), and Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2020 - 2027
Segments - by Product Types (Rx, and OTC), Applications (Interstitial Cystitis or Bladder Pain Syndrome, Pain Relief in Urethritis, Arthritis, Skin Discomfort, and Others), Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and E-Commerce), and Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2020 - 2027
The global lidocaine jelly and gels market was valued at USD 166.1 Million in 2019 and is projected to reach USD 216.5 Million by 2027, expanding at a CAGR of 3.7% during the forecast period. Demand for lidocaine jelly and gels is driven by the multiple applications such as dentistry, urology, and tattoos, growth of OTC drugs segment, rising adoption of e-pharmacies, and increasing healthcare expenditure.
Lidocaine is one of the prominent and commonly used medications used to numb the tissues. It is available in jelly, gels, injectable, spray, and others forms. It is used for facilitating anesthesia for various surgical procedures. Lidocaine numbs the tissues by blocking sodium channels, which in turn, creates an invisible barrier between the neurons of local tissues and makes them incapable of signaling the brain. It is considered as class Ib anti-arrhythmic agent owing to its varied usage such as decreasing muscle contractions, resulting in effects like hypotension, and irregular heart rate.
Lidocaine Jelly and Gels Market Dynamics
Lidocaine jelly is prominently used during catheter insertion. The cases related to urinary catheter insertion is rising. The Lidocaine gels is a primary product used during long catheterizations, as patients need numbness to bear long treatment schedules, which in turn, fuels the need for lidocaine gels, thereby propelling the market during the forecast period.
Lidocaine jelly helps in to manage pain caused by different chronic diseases such as arthritis, urethritis, and others. Generally, the lidocaine gel is applied externally on the skin surface which is absorbed by the skin to numb and reduce the pain in the area. Rising incidence rate of chronic diseases, especially in densely populated countries such as India and China, fuels demand for Lidocaine jelly to treat chronic diseases.
According to the National Center for Biotechnology Information, 33% of population in China and 49% of people India, aged 50 years and above, have been reported with at least one chronic condition. These figures proves the high need for Lidocaine jelly, which in turn, is expected to fuel the market during the forecast period.
The FDA has raised concerns regarding the usage of Lidocaine jelly and gels usage on infants and children, especially for tooth-related pains, as this can lead to serious implications such as seizures and brain damage. Various governmental bodies have raised concerns on the over usage of OTC Lidocaine jelly, as its extensive usage can lead to methemoglobinemia. Thus, implementation of rigid government regulations are likely to restrain the global lidocaine jelly and gels market.
Medical companies are developing alternative methods and products to treat ailments of individuals. Furthermore, doctors are preferring anesthetic from the ester group as Lidocaine (a classified amide) is allergic to some patients. Additionally, easy availability of Tramadol, Gabapentin, and growing number of substitutes which serve the same purpose is likely to impede the market during the forecast period.
Lidocaine is a local painkiller and a primary aid for many skin remedies. Besides this, Lidocaine is extensively used in cosmetic surgeries. Increase in the number of cosmetic surgeries boosts the demand for the jelly. Surge in the number of cosmetic surgeries is likely to create lucrative opportunities for Lidocaine jelly and gel manufacturers in the coming years.
Lidocaine Jelly and Gels Market Segmental Outlook
On the basis of product types, the global lidocaine jelly and gels market has been bifurcated into Rx and OTC. The Rx segment is expected to hold a significant share of the market during the forecast period due to high adoption of prescription drugs, as prescription drugs enable patients to opt for treatments that are suitable to their health orientations and medical history. The OTC segment is anticipated to hold a key share of the market and is projected to expand at a substantial CAGR during the forecast period.
In terms of applications, the global lidocaine jelly and gels market has been segmented into interstitial cystitis/bladder pain syndrome, pain relief in urethritis and others. The interstitial cystitis/bladder pain syndrome segment is expected to hold a significant share of the market and is anticipated to expand at a considerable CAGR during the forecast period.
The growth of this segment is attributed to the rising awareness regarding health among people and increasing incidences of bladder pain syndrome. The pain relief in urethritis segment is anticipated to account for a substantial share of the market and is projected to expand at a substantial CAGR during the forecast period. Growing usage of lidocaine gel for pain relief and rising number of cases of urethritis are boosting the segment’s growth.
Based on distribution channels, the global lidocaine jelly and gels market has been segregated into hospital pharmacy, retail pharmacy and e-commerce. The hospital pharmacy segment is expected to hold a significant share of the market and is anticipated to expand at a considerable CAGR during the forecast period. Hospitals carry out various surgeries, procedures, and treatments that utilize lidocaine jelly such as cystoscopy, cataract surgery, and endotracheal intubation, for which they use their pharmacy’s stock of drugs.
This, in turn, is fueling the hospital pharmacy segment. The retail pharmacy segment is anticipated to account for a sizeable share of the market and is projected to expand at a substantial CAGR during the forecast period, owing to the rising number of developments in remote areas, growing population, easy access to pharmacies, and increasing use of lidocaine gel for pain relief are propelling the segment.
Lidocaine Jelly and Gels Market Regional Outlook
On the basis of regions, the global job description management software market is fragmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The US holds a substantial share of the market. The market in the country is expected to expand at a considerable CAGR during the forecast period.
The demand for OTC drugs is rising in the US, as stores in the country often sell private label OTC products, which are extensively used due to the lower cost than the Rx products. Italy has the highest percentage of people adopting tattoos, which in turn, is propelling the market for lidocaine jelly and gels in the country.
Key Benefits for Industry Participants & Stakeholders
In-depth analysis of the global lidocaine jelly and gels market
Historical, current, and projected market size in terms of value (USD million) and volume (tons)
Potential & niche segments and regions exhibiting promising growth covered Industry drivers, restraints, and opportunities covered in the study
Prominent manufacturers operating in the global lidocaine jelly and gels market include Akorn, Incorporated, Aspen Pharmacare Holdings Limited, AstraZeneca, Curatio Healthcare Private Limited, ESBA Laboratories Inc., and FARCO-PHARMA GmbH.
These companies are considered as key manufacturers of lidocaine jelly and gels based on their revenue, research & development (R&D) activities, regional presence, and supply chain management system.
Chapter 1 Executive Summary Chapter 2 Assumptions and Acronyms Used Chapter 3 Research Methodology Chapter 4 Lidocaine Jelly and Gels Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Lidocaine Jelly and Gels Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Lidocaine Jelly and Gels Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Lidocaine Jelly and Gels Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Lidocaine Jelly and Gels Market Size & Forecast, 2017-2027 4.5.1 Lidocaine Jelly and Gels Market Size and Y-o-Y Growth 4.5.2 Lidocaine Jelly and Gels Market Absolute $ Opportunity 4.6 Impact of Key Regulations 4.7 Pipeline Analysis Chapter 5 Global Lidocaine Jelly and Gels Market Analysis and Forecast By Product Types 5.1 Introduction 5.1.1 Key Market Trends & Growth Opportunities By Product Types 5.1.2 Basis Point Share (BPS) Analysis By Product Types 5.1.3 Absolute $ Opportunity Assessment By Product Types 5.2 Lidocaine Jelly and Gels Market Size Forecast By Product Types 5.2.1 Rx 5.2.2 OTC 5.3 Market Attractiveness Analysis By Product Types Chapter 6 Global Lidocaine Jelly and Gels Market Analysis and Forecast By Applications 6.1 Introduction 6.1.1 Key Market Trends & Growth Opportunities By Applications 6.1.2 Basis Point Share (BPS) Analysis By Applications 6.1.3 Absolute $ Opportunity Assessment By Applications 6.2 Lidocaine Jelly and Gels Market Size Forecast By Applications 6.2.1 Interstitial Cystitis or Bladder Pain Syndrome 6.2.2 Pain Relief in Urethritis 6.2.3 Arthritis 6.2.4 Skin Discomfort 6.2.5 Others 6.3 Market Attractiveness Analysis By Applications Chapter 7 Global Lidocaine Jelly and Gels Market Analysis and Forecast By Distribution Channels 7.1 Introduction 7.1.1 Key Market Trends & Growth Opportunities By Distribution Channels 7.1.2 Basis Point Share (BPS) Analysis By Distribution Channels 7.1.3 Absolute $ Opportunity Assessment By Distribution Channels 7.2 Lidocaine Jelly and Gels Market Size Forecast By Distribution Channels 7.2.1 Hospital Pharmacies 7.2.2 Retail Pharmacies 7.2.3 E-Commerce 7.3 Market Attractiveness Analysis By Distribution Channels Chapter 8 Global Lidocaine Jelly and Gels Market Analysis and Forecast by Region 8.1 Introduction 8.1.1 Key Market Trends & Growth Opportunities by Region 8.1.2 Basis Point Share (BPS) Analysis by Region 8.1.3 Absolute $ Opportunity Assessment by Region 8.2 Lidocaine Jelly and Gels Market Size Forecast by Region 8.2.1 North America 8.2.2 Europe 8.2.3 Asia Pacific 8.2.4 Latin America 8.2.5 Middle East & Africa (MEA) 8.3 Market Attractiveness Analysis by Region Chapter 9 Coronavirus Disease (COVID-19) Impact 9.1 Introduction 9.2 Current & Future Impact Analysis 9.3 Economic Impact Analysis 9.4 Government Policies 9.5 Investment Scenario Chapter 10 North America Lidocaine Jelly and Gels Analysis and Forecast 10.1 Introduction 10.2 North America Lidocaine Jelly and Gels Market Size Forecast by Country 10.2.1 U.S. 10.2.2 Canada 10.3 Basis Point Share (BPS) Analysis by Country 10.4 Absolute $ Opportunity Assessment by Country 10.5 Market Attractiveness Analysis by Country 10.6 North America Lidocaine Jelly and Gels Market Size Forecast By Product Types 10.6.1 Rx 10.6.2 OTC 10.7 Basis Point Share (BPS) Analysis By Product Types 10.8 Absolute $ Opportunity Assessment By Product Types 10.9 Market Attractiveness Analysis By Product Types 10.10 North America Lidocaine Jelly and Gels Market Size Forecast By Applications 10.10.1 Interstitial Cystitis or Bladder Pain Syndrome 10.10.2 Pain Relief in Urethritis 10.10.3 Arthritis 10.10.4 Skin Discomfort 10.10.5 Others 10.11 Basis Point Share (BPS) Analysis By Applications 10.12 Absolute $ Opportunity Assessment By Applications 10.13 Market Attractiveness Analysis By Applications 10.14 North America Lidocaine Jelly and Gels Market Size Forecast By Distribution Channels 10.14.1 Hospital Pharmacies 10.14.2 Retail Pharmacies 10.14.3 E-Commerce 10.15 Basis Point Share (BPS) Analysis By Distribution Channels 10.16 Absolute $ Opportunity Assessment By Distribution Channels 10.17 Market Attractiveness Analysis By Distribution Channels Chapter 11 Europe Lidocaine Jelly and Gels Analysis and Forecast 11.1 Introduction 11.2 Europe Lidocaine Jelly and Gels Market Size Forecast by Country 11.2.1 Germany 11.2.2 France 11.2.3 Italy 11.2.4 U.K. 11.2.5 Spain 11.2.6 Russia 11.2.7 Rest of Europe 11.3 Basis Point Share (BPS) Analysis by Country 11.4 Absolute $ Opportunity Assessment by Country 11.5 Market Attractiveness Analysis by Country 11.6 Europe Lidocaine Jelly and Gels Market Size Forecast By Product Types 11.6.1 Rx 11.6.2 OTC 11.7 Basis Point Share (BPS) Analysis By Product Types 11.8 Absolute $ Opportunity Assessment By Product Types 11.9 Market Attractiveness Analysis By Product Types 11.10 Europe Lidocaine Jelly and Gels Market Size Forecast By Applications 11.10.1 Interstitial Cystitis or Bladder Pain Syndrome 11.10.2 Pain Relief in Urethritis 11.10.3 Arthritis 11.10.4 Skin Discomfort 11.10.5 Others 11.11 Basis Point Share (BPS) Analysis By Applications 11.12 Absolute $ Opportunity Assessment By Applications 11.13 Market Attractiveness Analysis By Applications 11.14 Europe Lidocaine Jelly and Gels Market Size Forecast By Distribution Channels 11.14.1 Hospital Pharmacies 11.14.2 Retail Pharmacies 11.14.3 E-Commerce 11.15 Basis Point Share (BPS) Analysis By Distribution Channels 11.16 Absolute $ Opportunity Assessment By Distribution Channels 11.17 Market Attractiveness Analysis By Distribution Channels Chapter 12 Asia Pacific Lidocaine Jelly and Gels Analysis and Forecast 12.1 Introduction 12.2 Asia Pacific Lidocaine Jelly and Gels Market Size Forecast by Country 12.2.1 China 12.2.2 Japan 12.2.3 South Korea 12.2.4 India 12.2.5 Australia 12.2.6 South East Asia (SEA) 12.2.7 Rest of Asia Pacific (APAC) 12.3 Basis Point Share (BPS) Analysis by Country 12.4 Absolute $ Opportunity Assessment by Country 12.5 Market Attractiveness Analysis by Country 12.6 Asia Pacific Lidocaine Jelly and Gels Market Size Forecast By Product Types 12.6.1 Rx 12.6.2 OTC 12.7 Basis Point Share (BPS) Analysis By Product Types 12.8 Absolute $ Opportunity Assessment By Product Types 12.9 Market Attractiveness Analysis By Product Types 12.10 Asia Pacific Lidocaine Jelly and Gels Market Size Forecast By Applications 12.10.1 Interstitial Cystitis or Bladder Pain Syndrome 12.10.2 Pain Relief in Urethritis 12.10.3 Arthritis 12.10.4 Skin Discomfort 12.10.5 Others 12.11 Basis Point Share (BPS) Analysis By Applications 12.12 Absolute $ Opportunity Assessment By Applications 12.13 Market Attractiveness Analysis By Applications 12.14 Asia Pacific Lidocaine Jelly and Gels Market Size Forecast By Distribution Channels 12.14.1 Hospital Pharmacies 12.14.2 Retail Pharmacies 12.14.3 E-Commerce 12.15 Basis Point Share (BPS) Analysis By Distribution Channels 12.16 Absolute $ Opportunity Assessment By Distribution Channels 12.17 Market Attractiveness Analysis By Distribution Channels Chapter 13 Latin America Lidocaine Jelly and Gels Analysis and Forecast 13.1 Introduction 13.2 Latin America Lidocaine Jelly and Gels Market Size Forecast by Country 13.2.1 Brazil 13.2.2 Mexico 13.2.3 Rest of Latin America (LATAM) 13.3 Basis Point Share (BPS) Analysis by Country 13.4 Absolute $ Opportunity Assessment by Country 13.5 Market Attractiveness Analysis by Country 13.6 Latin America Lidocaine Jelly and Gels Market Size Forecast By Product Types 13.6.1 Rx 13.6.2 OTC 13.7 Basis Point Share (BPS) Analysis By Product Types 13.8 Absolute $ Opportunity Assessment By Product Types 13.9 Market Attractiveness Analysis By Product Types 13.10 Latin America Lidocaine Jelly and Gels Market Size Forecast By Applications 13.10.1 Interstitial Cystitis or Bladder Pain Syndrome 13.10.2 Pain Relief in Urethritis 13.10.3 Arthritis 13.10.4 Skin Discomfort 13.10.5 Others 13.11 Basis Point Share (BPS) Analysis By Applications 13.12 Absolute $ Opportunity Assessment By Applications 13.13 Market Attractiveness Analysis By Applications 13.14 Latin America Lidocaine Jelly and Gels Market Size Forecast By Distribution Channels 13.14.1 Hospital Pharmacies 13.14.2 Retail Pharmacies 13.14.3 E-Commerce 13.15 Basis Point Share (BPS) Analysis By Distribution Channels 13.16 Absolute $ Opportunity Assessment By Distribution Channels 13.17 Market Attractiveness Analysis By Distribution Channels Chapter 14 Middle East & Africa (MEA) Lidocaine Jelly and Gels Analysis and Forecast 14.1 Introduction 14.2 Middle East & Africa (MEA) Lidocaine Jelly and Gels Market Size Forecast by Country 14.2.1 Saudi Arabia 14.2.2 South Africa 14.2.3 UAE 14.2.4 Rest of Middle East & Africa (MEA) 14.3 Basis Point Share (BPS) Analysis by Country 14.4 Absolute $ Opportunity Assessment by Country 14.5 Market Attractiveness Analysis by Country 14.6 Middle East & Africa (MEA) Lidocaine Jelly and Gels Market Size Forecast By Product Types 14.6.1 Rx 14.6.2 OTC 14.7 Basis Point Share (BPS) Analysis By Product Types 14.8 Absolute $ Opportunity Assessment By Product Types 14.9 Market Attractiveness Analysis By Product Types 14.10 Middle East & Africa (MEA) Lidocaine Jelly and Gels Market Size Forecast By Applications 14.10.1 Interstitial Cystitis or Bladder Pain Syndrome 14.10.2 Pain Relief in Urethritis 14.10.3 Arthritis 14.10.4 Skin Discomfort 14.10.5 Others 14.11 Basis Point Share (BPS) Analysis By Applications 14.12 Absolute $ Opportunity Assessment By Applications 14.13 Market Attractiveness Analysis By Applications 14.14 Middle East & Africa (MEA) Lidocaine Jelly and Gels Market Size Forecast By Distribution Channels 14.14.1 Hospital Pharmacies 14.14.2 Retail Pharmacies 14.14.3 E-Commerce 14.15 Basis Point Share (BPS) Analysis By Distribution Channels 14.16 Absolute $ Opportunity Assessment By Distribution Channels 14.17 Market Attractiveness Analysis By Distribution Channels Chapter 15 Competition Landscape 15.1 Lidocaine Jelly and Gels Market: Competitive Dashboard 15.2 Global Lidocaine Jelly and Gels Market: Market Share Analysis, 2019 15.3 Company Profiles (Details - Overview, Financials, Developments, Strategy) 15.3.1 Akorn, Incorporated 15.3.2 Aspen Pharmacare Holdings Limited 15.3.3 AstraZeneca 15.3.4 Curatio Healthcare Private Limited 15.3.5 ESBA Laboratories Inc. 15.3.6 FARCO-PHARMA GmbH 15.3.7 Gensco Pharma 15.3.8 Innovative Pharmaceuticals 15.3.9 Merit Pharmaceutical 15.3.10 Quest Products, Inc. 15.3.11 Septodont Healthcare India Pvt. Ltd. 15.3.12 Sidefarma
Ask for Research To Be Focused On Specific Regions or Segments
Receive Data As Per Your Format and Definition
Companies Profiled based on Your Requirements
Breaking Down Competitive Landscape as per Your Requirements
Any Level of Customization
Our Clients
Client Testinomials
We needed a highly accurate and precise report, which Growth Market Reports delivered promptly. The company compiled information from a wide array of reliable agencies and sourcess.It is extremely satisfactory to be working with you. Strategy Head of Major Tech Company
We were very pleased to contact Growth Market Reports as they tailored reports precisely as per our requirements. As we are dealing with the aerospace and defense industry, we need reports of high accuracy and substantial quality. Major Player in Defense Industry
Extremely delighted to have a well-crafted report on “Global Packaging Solutions Market Research Report” from your team. Thank you for providing me with all our requirements and for incorporating our suggestions. CMO of Leading Packaging Company from USA
I had a good experience working with Growth Market Reports as they were very open to all constructive changes in the report. I found that the report had its charm embedded with ample of data. Founder and Managing Partner of Major Korean Company
Our company has been working with Growth Market Reports for some years now and we are very happy with the quality of the reports provided by the company.I, on behalf of my organization, would like to thank you for offering professional reports. Global Consulting Firm
The base year considered for the global lidocaine jelly and gels market report is 2019. The complete analysis period is 2017 to 2027, wherein, 2017 & 2018 are the historic years and the forecast is provided from 2020 to 2027.
The market is expected to decrease around 1.2% in 2020, owing to the negative impact of COVID-19 pandemic on the global lidocaine jelly and gels market.
Demand for lidocaine jelly and gels is expected to continue to increase over the forecast period, taking into account multiple applications such as dentistry, urology, and tattoos, growth of OTC drugs segment, rising adoption of e-pharmacies, and increasing healthcare expenditure.
Applications in the global lidocaine jelly and gels market includes interstitial cystitis or bladder pain syndrome, pain relief in urethritis, arthritis, skin discomfort, and others.
In addition to market size (in USD Million) and, company market share (in % for base year 2019), other data such as Impact of Key Regulations, Pipeline Analysis, macro-economic factors and COVID-19 impact on the value chain are available in the final report.
According to the Growth Market Reports, the market for lidocaine jelly and gels is likely to register a CAGR of 3.7% during forecast period 2020-2027, with an anticipated valuation of USD 216.5 million by the end of 2027.
Request For Customization
Enquiry Before Buying
Speak With Analyst
